Hero Image

Medicare Coverage for Zepbound - A Complete Guide

Wondering if Medicare will help pay for Zepbound?

The answer changed in 2026. Medicare now has two routes: standard Part D coverage for certain medical uses, and a temporary program called the Medicare GLP-1 Bridge that covers Zepbound for weight management at a flat $50 a month for people who qualify.

This guide explains how each route works, who may be eligible, and exactly how to check and get coverage, because the rules depend on your plan, your diagnosis, and the form of Zepbound you're prescribed.

The Short Answer

  • Standard Medicare Part D still doesn't cover drugs used only for weight loss, but it may cover Zepbound for another approved use, such as moderate to severe obstructive sleep apnea (OSA) in adults with obesity, if your plan lists it.
  • The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. It covers the Zepbound KwikPen for weight management at $50 per month for eligible people with Part D coverage, after prior authorization.
  • The Bridge has limits. It covers only the KwikPen form of Zepbound, requires specific BMI and health criteria, and is temporary.

What Is Zepbound?

Zepbound (tirzepatide) is a once-weekly injectable medication. It's FDA-approved for chronic weight management in certain adults and for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity when used alongside diet and activity. Your prescriber determines whether it's clinically appropriate for you. Zepbound comes in more than one form, including the multi-dose KwikPen, single-dose pens, and single-dose vials, and the form matters for Medicare coverage, as explained below.

Zepbound works by activating GIP and GLP-1 receptors, which can help reduce appetite and improve metabolic measures. It's not insulin and isn't a substitute for insulin. It's typically used as part of a comprehensive plan that includes nutrition, physical activity, and ongoing medical follow-up.

Common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite. Serious risks are uncommon but can occur, so discuss your medical history (including pancreatitis, gallbladder disease, or thyroid tumors) with your clinician and review the Medication Guide before starting.

Medicare Basics: Do You Need Part D?

Most people qualify for Medicare at 65, and some qualify earlier because of a disability or certain conditions. Medicare has several parts: Part A covers hospital care, Part B covers outpatient medical services, Part C (Medicare Advantage) offers private all-in-one plans, and Part D covers prescription drugs. Self-injected drugs like Zepbound are generally a pharmacy benefit, which means you need Medicare drug coverage to use either route: either a standalone Part D plan with Original Medicare, or a Medicare Advantage plan that includes drug coverage (MA-PD). Original Medicare Parts A and B alone don't cover Zepbound.

Route 1: Standard Part D Coverage

Part D plans use a formulary (a list of covered drugs) and coverage rules. By law, Medicare Part D excludes drugs used only for weight loss. However, when a medication has an FDA-approved use that isn't excluded, such as treating OSA in adults with obesity, a Part D or MA-PD plan may cover it for that use if it's on the formulary. Coverage commonly involves prior authorization, step therapy, quantity limits, and preferred-pharmacy requirements, and your cost depends on your plan's tier, deductible, and copay structure.

How to check your plan

  1. Confirm your coverage type: Original Medicare with a standalone Part D plan, or a Medicare Advantage plan with drug coverage.
  2. Find your plan's formulary on its website or through the Medicare Plan Finder at Medicare.gov, and search for "Zepbound" and "tirzepatide." Note the tier, any prior authorization, and quantity limits.
  3. Check the rules for your diagnosis. Many plans cover medications only for specific approved uses and require documentation, such as a sleep study for OSA.
  4. Ask your prescriber to submit the documentation if prior authorization is required.
  5. Call Member Services on your plan card to confirm coverage, strengths, costs, and pharmacy requirements.
  6. If it's denied, ask for an exception or appeal. You can request a coverage determination, a formulary exception, or a tiering exception, and your prescriber's supporting letter is critical.

In 2026, Part D includes an annual cap of $2,100 on your out-of-pocket drug costs. Part D beneficiaries can also spread costs across the year with the Medicare Prescription Payment Plan.

Route 2: The Medicare GLP-1 Bridge

The Bridge is a temporary Medicare demonstration program that works around the weight-loss exclusion. It started July 1, 2026 and is scheduled to end December 31, 2027. It's run by Medicare, not by drug manufacturers or your plan, and it uses a single central processor (currently Humana, working as a Medicare contractor) for prior authorizations and pharmacy claims.

What it covers and what you pay

  • Covered drugs: Wegovy (injection or tablet), Foundayo (tablet), and the Zepbound KwikPen only. The single-dose Zepbound pens and the Zepbound vials are not covered under the Bridge.
  • Your cost: $50 for each 28- or 30-day supply, no matter your income level or dose.
  • It works outside your regular drug plan. The $50 doesn't count toward your Part D deductible or yearly out-of-pocket limit, and Bridge drugs aren't eligible for the Medicare Prescription Payment Plan.

Who qualifies

You must have Part D drug coverage and be prescribed the drug for weight management, and your prescriber must attest that you meet one of these clinical criteria, based on your BMI and health when you started treatment:

  • BMI of 35 or higher, with no additional condition required.
  • BMI of 30 to 34.9, plus heart failure with preserved ejection fraction, uncontrolled high blood pressure (despite two blood pressure medications), or chronic kidney disease stage 3a or higher.
  • BMI of 27 to 29.9, plus prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.

You must also be receiving counseling on lifestyle changes alongside the medication. Medicare.gov has an online eligibility tool, and you can call 1-800-MEDICARE with questions, but your prescriber has to confirm that you meet the requirements.

How to get it

  1. Talk to your prescriber about whether the Zepbound KwikPen is right for you and whether you meet the criteria.
  2. Have the prescription sent to your pharmacy. The pharmacy submits a claim to the Bridge, which checks your eligibility.
  3. Your prescriber completes a prior authorization. This goes to the Bridge's central processor, not to your own Part D plan. The pharmacy typically sends your prescriber the request within 24 to 72 hours, or the prescriber can use Medicare's electronic or fax form. A prescriber doesn't have to be enrolled in Medicare to submit it.
  4. Pick up your medicine and pay $50 for a one-month supply.

Switching from one GLP-1 drug to another requires a new prior authorization, and only 28- or 30-day fills are covered.

What happens after 2027? The Bridge is scheduled to end on December 31, 2027, and Medicare's plans for coverage after that are unclear, so ask your prescriber about a long-term plan.

Standard Part D vs. the Bridge

Standard Part D Medicare GLP-1 Bridge
What it covers Zepbound for approved non-excluded uses, such as OSA, if your plan lists it Weight management, for people who meet the BMI and health criteria
Zepbound forms Depends on your plan's formulary KwikPen only, not vials or single-dose pens
Your cost Varies by plan, tier, and deductible $50 per month
Counts toward the $2,100 cap? Yes No
Who approves it Your Part D or Medicare Advantage plan Medicare's central processor
How long it lasts Ongoing, but plans can change formularies each year July 1, 2026 through December 31, 2027

If You Don't Qualify or Can't Wait

  • Ask your prescriber about the right form. If you're prescribed vials or single-dose pens, the Bridge won't cover them, and your prescriber can tell you whether the KwikPen is an option.
  • Cash-pay options exist outside insurance. Manufacturer cash-pay prices for Zepbound have recently been listed from roughly $299 to $699 a month depending on the dose and the form, so confirm current prices. Cash purchases made outside your plan generally don't count toward your Part D out-of-pocket total.
  • Manufacturer copay cards generally can't be used with Medicare. Federal rules typically prohibit it.
  • Extra Help (the Low-Income Subsidy) may lower your Part D premiums and copays for covered drugs, and you can check eligibility with Social Security.
  • Free counseling: Your State Health Insurance Assistance Program (SHIP) can help you compare plans and understand coverage at no cost.
  • Compare plans during open enrollment. The Annual Enrollment Period runs October 15 through December 7. If your current plan won't cover Zepbound for your indication, compare drug coverage and consider switching.

Quick Answers to Common Questions

Does Original Medicare (Parts A and B) cover Zepbound?

No. Zepbound is a self-injected pharmacy drug, so coverage comes through Part D or a Medicare Advantage plan with drug coverage. You need drug coverage to use the Bridge, too.

Is Zepbound covered for weight loss?

Not under standard Part D. The temporary Bridge program is the exception, and only for the Zepbound KwikPen and only if you meet its criteria. Zepbound may also be covered under Part D for another approved use, such as OSA.

Can I use manufacturer coupons with Medicare?

Generally, no. Explore the Bridge, Extra Help, SHIP counseling, and your plan's payment options instead.

How is Zepbound different from Mounjaro?

Both contain tirzepatide, but Zepbound is labeled for weight management and OSA in certain adults, while Mounjaro is labeled for type 2 diabetes. Mounjaro is a Part D drug for diabetes and isn't part of the Bridge.

Will my Part D plan handle the Bridge prior authorization?

No. The Bridge uses its own central processor, and the request doesn't go to your plan. Make sure your prescriber's office knows this, since it differs from a normal drug prior authorization.

Action Checklist

  • Confirm you have Part D or Medicare Advantage drug coverage.
  • Ask your prescriber which form of Zepbound you need and why, and whether it's for weight management or another condition.
  • Check your BMI and conditions against the Bridge criteria, and use Medicare.gov's eligibility tool.
  • Have your prescriber submit the prescription and the Bridge prior authorization.
  • If it's for another approved use, check your plan's formulary and ask about prior authorization.
  • If you're denied, ask about exceptions and appeals, and call 1-800-MEDICARE or your SHIP for help.
  • Compare plans during open enrollment, October 15 to December 7.

Sources

Coverage rules are changing. Confirm details with Medicare.gov, 1-800-MEDICARE, your plan, and your healthcare provider. This article is general information, not medical advice.